Linezolid IP 600 mg Tablets (Lizosort-600) are a potent oxazolidinone-class antibiotic used to treat serious bacterial infections, including pneumonia, skin and soft tissue infections, and infections caused by drug-resistant bacteria such as MRSA and VRE. Linezolid works by inhibiting bacterial protein synthesis, helping stop bacterial growth and enabling effective infection control. It is especially valuable for infections that do not respond to conventional antibiotics, making Lizosort-600 a crucial option in advanced clinical therapy.
Linezolid 600 mg: A synthetic oxazolidinone antibiotic with strong activity against resistant gram-positive bacteria.
Effective Against Resistant Bacteria: Treats MRSA, VRE, and other multidrug-resistant infections.
Treats Pneumonia & Skin Infections: Widely used for hospital-acquired and community-acquired pneumonia, cellulitis, and complicated skin infections.
Strong Bacteriostatic Activity: Inhibits bacterial protein synthesis, preventing spread and promoting recovery.
Reliable Clinical Use: Trusted in hospitals and healthcare settings for severe infections.
Take orally as prescribed by the physician, with or without food. Complete the full course to ensure complete bacterial eradication.
May include headache, nausea, diarrhea, dizziness, anemia, or changes in blood counts. Report severe or persistent side effects to a healthcare professional.
Globus Labs brings you WHO-GMP–certified, high-quality Linezolid 600 mg sourced from reputed pharmaceutical manufacturers. Lizosort 600 is formulated to deliver safe, potent, and clinically trusted support.
Whether you’re seeking a franchise opportunity, exploring wholesale distribution, or evaluating Globus Labs for international trade, we’re here to help you build a strong, profitable partnership. Let’s discuss how we can grow together and create meaningful value for your business.